AGP Executive Report
Last update: an hour agoPublic Health: A Lancet Commission report says China invested about 1.4 trillion yuan in health-related poverty reduction from 2015 to 2020, combining healthcare and financial support with improvements in water, housing, nutrition and education. Out-of-pocket inpatient costs for people in poverty fell from 41% in 2013 to 31% in 2018. Drug Development: Sino Biopharmaceutical struck a cancer-drug partnership with Boehringer Ingelheim that could bring up to US$7 billion in milestone payments, covering six early-stage programs. Separately, Chinese biotech TJ Biopharma reported encouraging Phase 2 results for plonmarlimab in macrophage activation syndrome, including potential to reduce steroid use. Infectious Disease: A dengue outbreak at construction sites in Hainan has prompted the quarantine of thousands of workers. Prevention: A global study estimates replacing regular salt with potassium-enriched salt could prevent nearly three million deaths and 10 million new cardiovascular and kidney disease cases each year.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
